BUDZ · Weed, Inc.
$0.02
0.00 (-10.19%)
At close · Sep 4
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.97M
Shares
148.31M
BUDZ metrics
45 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.02
Market cap
$2.97M
Price action
19 metricsPrice change (1W)
-20.7%
Price change (30D)
+6.3%
Price change (3M)
-40.5%
Price change (6M)
-20.7%
Price change (YTD)
-40.5%
Price change (1Y)
-40.5%
Trailing year
Price change (5Y)
-91.8%
52-week high
$0.07
52-week low
$0.02
Change from 52-week high
-66.0%
Change from 52-week low
+19.0%
Annualized volatility
249.9%
Beta
-0.5
RSI (14D)
46.5
Price vs SMA 50
-10.1%
Price vs SMA 200
-28.0%
Avg volume (3M)
41,703
Relative volume
1.0
Average dollar volume
$1,062
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
148.31M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-24.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$1.05M
Net income (TTM)
−$1.10M
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+9.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-218.9%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$1.03M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1,066
Latest balance sheet
Cash & equivalents
$1,066
Total assets
$504,025
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$201,083
Capital expenditures (TTM)
$0
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
41 / 100
Insider activity
2 metricsNet insider buying (90D)
−$24,500
Insider-sentiment score
43 / 100
Risk flags
1 metricsGoing concern
Flagged